Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial
Research output: Contribution to journal › Comment/debate › Research › peer-review
| Original language | English |
|---|---|
| Journal | British Journal of Haematology |
| Volume | 196 |
| Issue number | 2 |
| Pages (from-to) | 437-440 |
| Number of pages | 4 |
| ISSN | 0007-1048 |
| DOIs |
|
| Publication status | Published - 2022 |
ID: 346779530